A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.
Kurrle
E
E
Abteilung Innere Medizin III, Medizinische Universitätsklinik, Ulm, Federal Republic of Germany.
Ehninger
G
G
Freund
M
M
Heil
G
G
Hoelzer
D
D
Link
H
H
Mitrou
P S
PS
Ohl
S
S
Queisser
W
W
Schlimok
G
G
D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007239:Infections / Q000139:chemically induced; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D012074:Remission Induction; D013921:Thrombocytopenia / Q000139:chemically induced
D003561:Cytarabine; D005047:Etoposide; D003630:Daunorubicin